General Western Blot Reagents
![Abcam Anti-RPS6 antibody [RP23040083].](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502700118.JPG-250.jpg)
Abcam Anti-RPS6 antibody [RP23040083].
Anti-RPS6 antibody [RP23040083].
The product is subject to the following: Abcam Restricted Use Statement
Abcam Antibiotic PF 1052, Neutrophil migration inhibitor, 500UG
MW 429.59 g/mol, Purity >98%. Neutrophil migration inhibitor. Antibacterial and potentially antifungal and phytotoxic properties. Active in vivo and in vitro. See similar compound
The product is subject to the following: Abcam Restricted Use Statement
Abcam Fast green FCF, tissue and protein stain, 5G
MW 808.86 g/mol. Widely utilized tissue and protein stain. Used as a quantitative stain for histones at alkaline pH after acid extraction of DNA and as a protein stain in IEF (isoelectric focusing) and SDS-PAGE electrophoresis. Fluoresces in the near-infrared (NIR). Recommended as a replacement for Light Green SF yellowish in Masson's trichrome as its color is more brilliant and less likely to fade. Also used as a food dye.
The product is subject to the following: Abcam Restricted Use Statement
Abcam KAT13D / CLOCK peptide, 50UG
KAT13D / CLOCK peptide. >95% purity and suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: BHLHE8, KIAA0334, CLOCK, Circadian locomoter output cycles protein kaput, hCLOCK, Class E basic helix-loop-helix protein 8, bHLHe8
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bufalin, Na+/K+-ATPase inhibitor, 50MG
MW 386.5 Da, Purity >98%. Na+/K+-ATPase inhibitor. Potent steroid receptor coactivators SRC-3 and SRC-1 inhibitor. Induces cell differentiation and apoptosis. Activates AP-1 via JNK. Shows antitumor effects *in vivo.*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human GLP2 peptide, 100UG
Human GLP2 peptide is a Synthetic blocking peptide. >=95% purity and suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: Glucagon-like peptide 2 receptor, GLP-2 receptor, GLP-2-R, GLP-2R, GLP2R
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam PR 619, DUB inhibitor, 5MG
MW 223.3 Da, Purity >99%. Cell-permeable, non-selective and reversible DUB inhibitor (IC₅₀ values are 5 to 20 μM). Induces polyubiquitinated protein accumulation in cells without directly affecting proteasome activity. Activates autophagy.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Anisomycin, Protein synthesis inhibitor, 50MG
MW 265.3 Da, Purity >98%. Translational inhibitor of protein synthesis. Highly potent activator of kinase cascades. Potently activates stress-activated protein kinases, p38, JNK MAP and other kinases.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Imiquimod, Toll-like receptor 7 agonist, 100MG
MW 240.3 Da, Purity >95%. Toll-like receptor 7 agonist. Activates NF-κB and stimulates pro-inflammtory cytokines. Immunomodulator, antiviral and antitumor agent. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ceftria x one disodium salt hemi(heptahydrate), beta-Lactam antibiotic, 50MG
MW 1323.2 Da, Purity >98%. Ceftriaxone disodium salt hemi(heptahydrate), beta-Lactam antibiotic. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SBD-F (7-Fluorobenzofurazan-4-sulfonic acid ammonium salt), Fluorescent thiol indicator, 25MG
MW 235.2 Da, Purity >98%. Fluorescent thiol indicator. Reacts with sulfhydryl groups to produce highly fluorescent compounds. Attains low detection limits.
The product is subject to the following: Abcam Restricted Use Statement
Abcam NPS 2143 hydrochloride, Ca2+-sensing receptor antagonist, 50MG
MW 445.4 Da, Purity >99%. Potent, selective Ca2+-sensing receptor antagonist (IC50 = 43 nM). Stimulates parathyroid hormone secretion (EC50 = 41 nM). Shows antihypertensive effects *in vivo.* Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam CAY10585, HIF-1alpha inhibitor, 5MG
MW 435.5 Da, Purity >97%. HIF-1α inhibitor (IC₅₀ values are 2.6 and 0.7 μM for Hep3B and AGS cell lines respectively). Suppresses transcription of HIF-1 target genes VEGF and erythropoietin at 10 μM. Attenuates hypoxia-induced ANP secretion. Blunts BMP9-induced osteogenic signaling in MSCs.
The product is subject to the following: Abcam Restricted Use Statement
Abcam BML 284, Wnt signaling activator, 25MG
MW 350.4 Da, Purity >98%. Cell-permeable Wnt signaling activator. Induces β-catenin and TCF-dependent transcriptional activity (EC₅₀ = 0.7 μM). Activates Wnt without inhibiting GSK-3β.Shows developmental effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam 3-Cyano-7-etho x ycoumarin, Fluorogenic cytochrome P450 monoo x ygenase substrate, 100MG
MW 215.2 g/mol, Purity >99%. Fluoreogenic cytochrome P450 mixed-function monooxygenase substrate. Metabolized to the fluorescent compound 3-cyano-7-hydroxycoumarin. About 50-100 times more sensitive than conventional substrate ethoxy-resorufin due to higher turn over rate.
The product is subject to the following: Abcam Restricted Use Statement